Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Design of an enantioselective artificial metallo-hydratase enzyme containing an unnatural metal-binding amino acid

  • Drienovská, Ivana
  • Alonso-Cotchico, Lur|||0000-0002-0172-6394
  • Vidossich, Pietro
  • Lledós, Agustí|||0000-0001-7909-422X
  • Maréchal, Jean-Didier|||0000-0002-8344-9043
  • Roelfes, Gerard|||0000-0002-0364-9564
Starting from biochemical knowledge followed by computational design, an artificial metallo-hydratase comprising an unnatural metal binding amino acid was created. The design of artificial metalloenzymes is a challenging, yet ultimately highly rewarding objective because of the potential for accessing new-to-nature reactions. One of the main challenges is identifying catalytically active substrate-metal cofactor-host geometries. The advent of expanded genetic code methods for the in vivo incorporation of non-canonical metal-binding amino acids into proteins allow to address an important aspect of this challenge: the creation of a stable, well-defined metal-binding site. Here, we report a designed artificial metallohydratase, based on the transcriptional repressor lactococcal multidrug resistance regulator (LmrR), in which the non-canonical amino acid (2,2'-bipyridin-5yl)alanine is used to bind the catalytic Cu() ion. Starting from a set of empirical pre-conditions, a combination of cluster model calculations (QM), protein-ligand docking and molecular dynamics simulations was used to propose metallohydratase variants, that were experimentally verified. The agreement observed between the computationally predicted and experimentally observed catalysis results demonstrates the power of the artificial metalloenzyme design approach presented here.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Computational insight into the catalytic implication of head/tail-first orientation of arachidonic acid in human 5-lipoxygenase, consequences for the positional specificity of oxygenation

  • Saura Martínez, Patricia
  • Maréchal, Jean-Didier|||0000-0002-8344-9043
  • Masgrau, Laura|||0000-0003-4495-508X
  • Lluch, José M.|||0000-0002-7536-1869
  • González Lafont, Àngels|||0000-0003-0729-2483
In the present work we have combined homology modeling, protein-ligand dockings, quantum mechanics/molecular mechanics calculations and molecular dynamics simulations to generate human 5-lipoxygenase (5-LOX):arachidonic acid (AA) complexes consistent with the 5-lipoxygenating activity (which implies hydrogen abstraction at the C position). Our results suggest that both the holo and the apo forms of human Stable 5-LOX could accommodate AA in a productive form for 5-lipoxygenation. The former, in a tail-first orientation, with the AA carboxylate end interacting with Lys409, gives the desired structures with C close to the Fe-OH cofactor and suitable barrier heights for H abstraction. Only when using the apo form structure, a head-first orientation with the AA carboxylate close to His600 (a residue recently proposed as essential for AA positioning) is obtained in the docking calculations. However, the calculated barrier heights for this head-first orientation are in principle consistent with 5-LOX specificity, but also with 12/8 regioselectivity. Finally, long MD simulations give support to the recent hypothesis that the Phe177 + Tyr181 pair needs to close the active site access during the chemical reaction, and suggest that in the case of a head-first orientation Phe177 may be the residue interacting with the AA carboxylate.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prediction of the interaction of metallic moieties with proteins, An update for protein-ligand docking techniques

  • Sciortino, Giuseppe|||0000-0001-9657-1788
  • Rodríguez-Guerra Pedregal, Jaime|||0000-0001-8974-1566
  • Lledós, Agustí|||0000-0001-7909-422X
  • Garribba, Eugenio|||0000-0002-7229-5966
  • Maréchal, Jean-Didier|||0000-0002-8344-9043
In this article, we present a new approach to expand the range of application of protein-ligand docking methods in the prediction of the interaction of coordination complexes (i.e., metallodrugs, natural and artificial cofactors, etc.) with proteins. To do so, we assume that, from a pure computational point of view, hydrogen bond functions could be an adequate model for the coordination bonds as both share directionality and polarity aspects. In this model, docking of metalloligands can be performed without using any geometrical constraints or energy restraints. The hard work consists in generating the convenient atom types and scoring functions. To test this approach, we applied our model to 39 high-quality X-ray structures with transition and main group metal complexes bound via a unique coordination bond to a protein. This concept was implemented in the protein-ligand docking program GOLD. The results are in very good agreement with the experimental structures: the percentage for which the RMSD of the simulated pose is smaller than the X-ray spectra resolution is 92.3% and the mean value of RMSD is < 1.0 Å. Such results also show the viability of the method to predict metal complexes-proteins interactions when the X-ray structure is not available. This work could be the first step for novel applicability of docking techniques in medicinal and bioinorganic chemistry and appears generalizable enough to be implemented in most protein-ligand docking programs nowadays available.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Decoding Surface Interaction of VIVO Metallodrug Candidates with Lysozyme

  • Sciortino, Giuseppe|||0000-0001-9657-1788
  • Sanna, Daniele|||0000-0001-9299-0141
  • Ugone, Valeria|||0000-0002-2830-3869
  • Lledós, Agustí|||0000-0001-7909-422X
  • Maréchal, Jean-Didier|||0000-0002-8344-9043
  • Garribba, Eugenio|||0000-0002-7229-5966
The interaction of metallodrugs with proteins influences their transport, uptake, and mechanism of action. In this study, we present an integrative approach based on spectroscopic (EPR) and computational (docking) tools to elucidate the noncovalent binding modes of various VIVO compounds with lysozyme, a prototypical model of protein receptor. Five VIVO-flavonoid drug candidates formed by quercetin (que), morin (mor), 7,8-dihydroxyflavone (7,8-dhf), chrysin (chr), and 5-hydroxyflavone (5-hf) - effective against several osteosarcoma cell lines - and two benchmark VIVO species of acetylacetone (acac) and catechol (cat) are evaluated. The results show a gradual variation of the EPR spectra at room temperature, which is associated with the strength of the interaction between the square pyramidal complexes [VOL2] and the surface residues of lysozyme. The qualitative strength of the interaction from EPR is [VO(que)2]2- ? [VO(mor)2] > [VO(7,8-dhf)2]2- > [VO(chr)2] ? [VO(5-hf)2] > [VO(acac)2] ? [VO(cat)2]2-. This observation is compared with protein-ligand docking calculations with GOLD software examining the GoldScore scoring function (F), for which hydrogen bond and van der Waals contact terms have been optimized to account for the surface interaction. The best predicted binding modes display an energy trend in good agreement with the EPR spectroscopy. Computation indicates that the strength of the interaction can be predicted by the Fmax value and depends on the number of OH or CO groups of the ligands that can interact with different sites on the protein surface and, more particularly, with those in the vicinity of the active site of the enzyme. The interaction strength determines the type of signal revealed (rigid limit, slow tumbling, or isotropic) in the EPR spectra. Spectroscopic and computational results also suggest that there are several sites with comparable binding energy, with the V complexes distributing among them in a bound state and in aqueous solution in an unbound state. This kind of study and analysis could be generalized to determine the noncovalent binding modes of a generic metal species with a generic protein.